- Chapter 5. Ischaemic heart disease: Coronary restenosis and stent thrombosis2011 | Third Faculty of Medicine
- Late stents thrombosis - a new, infrequent yet serious complication2006 | First Faculty of Medicine
- Clopidogrel resistance "Live" - the risk of stent thrombosis should be evaluated before procedures2009 | First Faculty of Medicine, Third Faculty of Medicine
- High-residual platelet activity despite dual antiplatelet treatment associated with subacute stent thrombosis2009 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Management of Antiplatelet Therapy in Patients at Risk for Coronary Stent Thrombosis Undergoing Non-Cardiac Surgery2011 | Third Faculty of Medicine
- Stent thrombosis in acute coronary syndromes: Patient-related factors and operator-related factors2020 | Third Faculty of Medicine
- Stent Thrombosis-Risk Assessment and Prevention2010 | Third Faculty of Medicine
- Subacute stent thrombosis associated with high residual platelet activity2009 | Second Faculty of Medicine
- The lack of endothelization after drug-eluting stent implantation as a cause of fatal late stent thrombosis2008 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Late stents thrombosis - a new, infrequent yet serious complication +12006 | Faculty of Medicine in Hradec Králové
- Stent Thrombosis After ACS-PCI: Does Adherence to Antiplatelet Therapy Involve More Than Its Intensity?2019 | Third Faculty of Medicine
- Antithrombotic therapy in patients at risk for coronary stent thrombosis undergoing non-cardiac surgery2010 | Third Faculty of Medicine
- Subacute thrombosis of two stents as a cause of acute myocardial infarction2009 | Third Faculty of Medicine
- Suboptimal stent apposition - treat or leave it?2016 | First Faculty of Medicine
- Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE- ABSORB randomised clinical trial2020 | Third Faculty of Medicine
- One-Year Clinical and Computed Tomography Angiographic Outcomes After Bioresorbable Vascular Scaffold Implantation During Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction The PRAGUE-19 Study2015 | Third Faculty of Medicine
- Randomized Comparison of Endothelial Progenitor Cells Capture Stent Versus Cobalt-Chromium Stent for Treatment of ST-Elevation Myocardial Infarction. Six-Month Clinical, Angiographic, and IVUS Follow-Up2010 | Third Faculty of Medicine, Central Library of Charles University
- Serious Complication of Percutaneous Angioplasty with Stent Implantation in so Called "Chronic Cerebrospinal Venous Insufficiency" in Multiple Sclerosis Patient2012 | First Faculty of Medicine
- Chapter 3: Emergency Percutaneous Coronary Intervention2012 | Third Faculty of Medicine
- Clinical results with the Resolute zotarolimus-eluting stent in total coronary occlusions2015 | Third Faculty of Medicine
- Long-Term Health Outcome and Mortality Evaluation After Invasive Coronary Treatment Using Drug Eluting Stents with or without the IVUS Guidance. Randomized Control Trial. HOME DES IVUS2010 | Publication without faculty affiliation
- How would I treat?2015 | Third Faculty of Medicine
- Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events2013 | Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Anti-platelet treatment: switching from clopidogrel to prasugrel2012 | Publication without faculty affiliation
- Long-term health outcome and mortality evaluation after invasive coronary treatment using drug-eluting stents: HOME DES registry2007 | First Faculty of Medicine
- Long-term outcomes of patients receiving zotarolimus-eluting stents in ST elevation myocardial infarction, non-ST elevation acute coronary syndrome, and stable angina: Data from the Resolute program2013 | Third Faculty of Medicine
- Resolute zotarolimus-eluting coronary stent system for the treatment of coronary artery disease2014 | Third Faculty of Medicine
- Clopidogrel Before Elective Percutaneous Coronary Intervention2010 | Third Faculty of Medicine
- Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents2014 | Faculty of Medicine in Hradec Králové